Pharma Reviews: Indian pharma takes M&A route to build a global footprint

Ranbaxy alone took $3.2 billion for Sun Pharma, the largest transaction in the Indian industry. Not to be left out, Lupin struck the biggest deal last year ...
Read more: Indian pharma takes M&A route to build a global footprint